Pi Life Science Research Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 15-12-2024
- Paid Up Capital ₹ 1.50 Cr
as on 15-12-2024
- Company Age 20 Year, 21 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 16.71%
(FY 2022)
- Profit 235.51%
(FY 2022)
- Ebitda 256.11%
(FY 2022)
- Net Worth 12.09%
(FY 2022)
- Total Assets 12.00%
(FY 2022)
About Pi Life Science Research
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajendra Kapoor, Rajnish Sarna, and Atulkumar Gupta serve as directors at the Company.
- CIN/LLPIN
U73100DL2004PLC131109
- Company No.
131109
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
09 Dec 2004
- Date of AGM
18 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pi Life Science Research?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Kapoor  | Director | 20-May-2015 | Current |
| Rajnish Sarna | Director | 08-Jun-2013 | Current |
| Atulkumar Gupta | Director | 06-Nov-2023 | Current |
Financial Performance of Pi Life Science Research.
Pi Life Science Research Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.71% increase. The company also saw a substantial improvement in profitability, with a 235.51% increase in profit. The company's net worth Soared by an impressive increase of 12.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pi Life Science Research?
In 2021, Pi Life Science Research had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Pi Bioferma Private LimitedActive 4 years 3 months
Rajnish Sarna and Atulkumar Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pi Life Science Research?
Pi Life Science Research has a workforce of 3 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pi Life Science Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pi Life Science Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
